⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DARE News
Dare Bioscience, Inc. Common Stock
Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026
globenewswire.com
DARE
Form 8-K
sec.gov
DARE
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth
globenewswire.com
DARE
Daré Bioscience Participates in Virtual Investor “What This Means” Segment
globenewswire.com
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
globenewswire.com
DARE
Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
globenewswire.com
DARE
DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility
globenewswire.com
DARE
Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
globenewswire.com
DARE